PortfoliosLab logoPortfoliosLab logo
JNJ vs. LEG
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

JNJ vs. LEG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Johnson & Johnson (JNJ) and Leggett & Platt, Incorporated (LEG). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, JNJ achieves a 13.43% return, which is significantly higher than LEG's -8.64% return. Over the past 10 years, JNJ has outperformed LEG with an annualized return of 10.06%, while LEG has yielded a comparatively lower -11.64% annualized return.


JNJ

1D
-0.26%
1M
5.50%
YTD
13.43%
6M
16.43%
1Y
53.49%
3Y*
16.56%
5Y*
10.04%
10Y*
10.06%

LEG

1D
-0.10%
1M
-0.60%
YTD
-8.64%
6M
-8.50%
1Y
12.07%
3Y*
-29.34%
5Y*
-25.68%
10Y*
-11.64%
*Multi-year figures are annualized to reflect compound growth (CAGR)

JNJ vs. LEG - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
JNJ
Johnson & Johnson
13.43%47.48%-4.81%-8.58%5.97%11.44%10.82%16.22%-5.13%24.43%
LEG
Leggett & Platt, Incorporated
-8.64%17.02%-61.93%-13.45%-17.78%-3.76%-9.05%47.13%-22.25%0.58%

Correlation

The correlation between JNJ and LEG is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.16

Correlation (3Y)
Calculated over the trailing 3-year period

0.22

Correlation (5Y)
Calculated over the trailing 5-year period

0.21

Correlation (10Y)
Calculated over the trailing 10-year period

0.22

Correlation (All Time)
Calculated using the full available price history since Nov 6, 1987

0.23

Fundamentals

Market Cap

JNJ:

$567.68B

LEG:

$1.41B

EPS

JNJ:

$8.65

LEG:

$1.60

PE Ratio

JNJ:

26.85

LEG:

6.25

PS Ratio

JNJ:

5.86

LEG:

0.46

PB Ratio

JNJ:

6.99

LEG:

1.36

Total Revenue (TTM)

JNJ:

$96.36B

LEG:

$3.03B

Gross Profit (TTM)

JNJ:

$66.60B

LEG:

$717.40M

EBITDA (TTM)

JNJ:

$31.62B

LEG:

$433.10M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

JNJ vs. LEG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

JNJ
JNJ Risk / Return Rank: 9595
Overall Rank
JNJ Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
JNJ Sortino Ratio Rank: 9797
Sortino Ratio Rank
JNJ Omega Ratio Rank: 9595
Omega Ratio Rank
JNJ Calmar Ratio Rank: 9292
Calmar Ratio Rank
JNJ Martin Ratio Rank: 9393
Martin Ratio Rank

LEG
LEG Risk / Return Rank: 5151
Overall Rank
LEG Sharpe Ratio Rank: 5151
Sharpe Ratio Rank
LEG Sortino Ratio Rank: 5050
Sortino Ratio Rank
LEG Omega Ratio Rank: 4949
Omega Ratio Rank
LEG Calmar Ratio Rank: 5252
Calmar Ratio Rank
LEG Martin Ratio Rank: 5252
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

JNJ vs. LEG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Johnson & Johnson (JNJ) and Leggett & Platt, Incorporated (LEG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


JNJLEGDifference
Sharpe ratioReturn per unit of total volatility

+2.95

Sortino ratioReturn per unit of downside risk

+3.88

Omega ratioGain probability vs. loss probability

1.57

1.09

+0.48

Calmar ratioReturn relative to maximum drawdown

4.91

0.43

+4.48

Martin ratioReturn relative to average drawdown

14.52

0.89

+13.63

JNJ vs. LEG - Sharpe Ratio Comparison

The current JNJ Sharpe Ratio is 3.19, which is higher than the LEG Sharpe Ratio of 0.25. The chart below compares the historical Sharpe Ratios of JNJ and LEG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


JNJLEGDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

3.19

0.25

+2.95

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.60

-0.61

+1.21

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.55

-0.29

+0.84

Sharpe Ratio (All Time)

Calculated using the full available price history

0.54

0.20

+0.34

Drawdowns

JNJ vs. LEG - Drawdown Comparison

The maximum JNJ drawdown since its inception was -50.67%, smaller than the maximum LEG drawdown of -86.41%. Use the drawdown chart below to compare losses from any high point for JNJ and LEG.


Loading charts...

Drawdown Indicators


JNJLEGDifference

Max Drawdown

Largest peak-to-trough decline

-50.67%

-86.41%

+35.74%

Max Drawdown (1Y)

Largest decline over 1 year

-10.96%

-28.51%

+17.55%

Max Drawdown (3Y)

Largest decline over 3 years

-15.95%

-77.39%

+61.44%

Max Drawdown (5Y)

Largest decline over 5 years

-18.41%

-85.42%

+67.01%

Max Drawdown (10Y)

Largest decline over 10 years

-27.37%

-86.41%

+59.04%

Current Drawdown

Current decline from peak

-6.06%

-78.87%

+72.81%

Average Drawdown

Average peak-to-trough decline

-11.88%

-19.63%

+7.75%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.70%

13.58%

-9.88%

Volatility

JNJ vs. LEG - Volatility Comparison

The current volatility for Johnson & Johnson (JNJ) is 5.80%, while Leggett & Platt, Incorporated (LEG) has a volatility of 11.27%. This indicates that JNJ experiences smaller price fluctuations and is considered to be less risky than LEG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


JNJLEGDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.80%

11.27%

-5.47%

Volatility (6M)

Calculated over the trailing 6-month period

12.41%

30.79%

-18.38%

Volatility (1Y)

Calculated over the trailing 1-year period

16.87%

49.55%

-32.68%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

16.87%

42.40%

-25.53%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.47%

39.77%

-21.30%

Dividends

JNJ vs. LEG - Dividend Comparison

JNJ's dividend yield for the trailing twelve months is around 2.26%, more than LEG's 2.00% yield.


PositionTTM20252024202320222021202020192018201720162015
JNJ
Johnson & Johnson
2.26%2.48%3.40%3.00%2.52%2.45%2.53%2.57%2.74%2.38%2.73%2.87%
LEG
Leggett & Platt, Incorporated
2.00%1.82%6.35%6.95%5.40%4.03%3.61%3.11%4.19%2.98%2.74%3.00%

Financials

JNJ vs. LEG - Financials Comparison

This section allows you to compare key financial metrics between Johnson & Johnson and Leggett & Platt, Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00B25.00B20222023202420252026
24.06B
0
(JNJ) Total Revenue
(LEG) Total Revenue
Values in USD except per share items

Frequently Asked Questions


JNJ and LEG have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

LEG has higher volatility (11.27%) compared to JNJ (5.80%). In terms of maximum drawdown, JNJ dropped -50.67% vs LEG's -86.41%.

JNJ currently has the higher Sharpe Ratio (3.19 vs 0.25), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for JNJ and LEG

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer